Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04872985
Status:
RECRUITING
Last Update Posted:
2021-05-05
First Post:
2021-04-29
Brief Title:
Pyrotinib in Combination With Neoadjuvant Chemotherapy in HRHER2- HER4 High Expression Breast Cancer Patients A Phase II Trial
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization Data
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Class:
OTHER
Study ID:
MA-BC-II-018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead Sponsor Class:
OTHER
Responsible Party:
Erwei Song MD PhD
Responsible Party Title:
MDPhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Jiangsu HengRui Medicine Co Ltd | INDUSTRY |